logo

ASMB

Assembly Biosciences·NASDAQ
--
--(--)
--
--(--)

ASMB fundamentals

Assembly Biosciences (ASMB) released its earnings on Nov 10, 2025: revenue was 10.79M (YoY +57.62%), beat estimates; EPS was -0.72 (YoY +52.32%), beat estimates.
Revenue / YoY
10.79M
+57.62%
EPS / YoY
-0.72
+52.32%
Report date
Nov 10, 2025

Earnings

EPS
Revenue

Revenue & Expenses

ASMB has released its 2025 Q4 earnings report, with revenue of 42.47M, reflecting a YoY change of 477.26%, and net profit of 22.09M, showing a YoY change of 313.74%. The Sankey diagram below clearly presents ASMB's revenue sources and cost distribution.

Key Indicators

Assembly Biosciences (ASMB) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Assembly Biosciences (ASMB)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown

Balance Sheet

Assembly Biosciences (ASMB)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown

Cash Flow

Assembly Biosciences (ASMB)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown

Revenue Breakdown

Where does Assembly Biosciences (ASMB) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:

Dividend

Track Assembly Biosciences (ASMB) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield